KMDA
Kamada Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth +28.6% ·
share flow +8.6% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 27 | +5 | 2.57M | $19.13M | +6 | −1 |
| Q1 2026 | 22 | -3 | 2.50M | $509.41M | +1 | −4 |
| Q4 2025 | 25 | -1 | 2.61M | $442.17M | — | −1 |
| Q3 2025 | 12 | 0 | 1.99M | $13.83M | — | — |
| Q2 2025 | 9 | +2 | 1.71M | $13.25M | +2 | — |
| Q1 2025 | 6 | +2 | 1.56M | $10.32M | +2 | — |
| Q4 2024 | 4 | 0 | 1.20M | $7.32M | — | — |
| Q3 2024 | 4 | 0 | 1.28M | $6.90M | — | — |
| Q2 2024 | 4 | — | 993.01K | $4.93M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 832.00K | +2.9% | $6.45M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 2 | ARK Investment Management ✦ | 253.27K | New | $1.97M | 0.0% | New | 1 | SEC ↗ |
| 3 | Millennium Management ✦ | 230.10K | -48.7% | $1.78M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 4 | Marshall Wace ✦ | 152.64K | -14.2% | $1.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Marshall Wace ✦ | 152.64K | -14.2% | $1.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 105.08K | +208.3% | $814,409 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 60.56K | New | $471,876 | 0.0% | New | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 33.38K | -47.3% | $258,680 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 29.41K | +0.4% | $227,919 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 12.41K | — | $96,186 | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 12.41K | — | $96,186 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| ARK Investment Management | $1.97M | 0.0% |
| Arrowstreet Capital | $471,876 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 41 holders, 5.10M shares, $528.34M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.